China SXT Pharmaceuticals Inc (SXTC NASDAQ) stock market data APIs
$1.7352
-0.05(-2.9%)
as of June 30, 2025
Try our APIs with
free plan!
China SXT Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.
Prev. Close
1.7352
Open
1.6898
High
1.7963
Low
1.6651
52 wk Range
0.95-11.92
Market Cap
200 M
P/E Ratio
0.0138
Shares Outstanding
116 M
Revenue
1 818 K
EPS
-2.03
Beta
1.099
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get China SXT Pharmaceuticals Inc data using free add-ons & libraries
Get China SXT Pharmaceuticals Inc Fundamental Data
China SXT Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 1 818 K
- EBITDA: 6 787 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2022-07-18
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
China SXT Pharmaceuticals Inc News
New
US Undiscovered Gems 3 Small Caps to Watch
The United States market has experienced a flat week, yet it boasts an impressive 11% increase over the past year with earnings projected to grow by 15% annually. In this environment, identifying smal...
US Market's Top 3 Undiscovered Gems with Strong Fundamentals
In the last week, the United States market has been flat, but it has risen by 10.0% over the past year with earnings forecasted to grow by 15% annually. In this environment, stocks with strong fundame...
China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency
TAIZHOU, China, March 17, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (Nasdaq: SXTC) (the “Company”), a specialty pharmaceutical company focusing on the research, development, ma...
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
TAIZHOU, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, deve...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
